# Sirolimus Treatment Of Patients With SLE

> **NCT04736953** · PHASE2 · NOT_YET_RECRUITING · sponsor: **State University of New York - Upstate Medical University** · enrollment: 220 (estimated)

## Conditions studied

- Lupus Erythematosus, Systemic

## Interventions

- **DRUG:** Sirolimus
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04736953
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2029-01-01
- **Final completion:** 2029-01-01
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2023-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04736953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04736953, "Sirolimus Treatment Of Patients With SLE". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04736953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*